Abstract
Background: Sentinel lymph node (SLN) biopsy with the standard intraparenchymal injection has been accepted as an alternative to routine axillary dissection for patients with breast cancer. However, the identification and false-negative rates with this method can vary widely from surgeon to surgeon. The subareolar location contains a rich lymphatic network and represents a potential site of injection for SLN identification.
Methods: Between August 1, 1999, and December 31, 2000, we performed 159 SLN biopsy procedures on 158 patients with breast cancer. For each patient,99mTc-labeled sulfur colloid was injected into the subareolar location, and 1% isosulfan blue dye was given as an intraparenchymal injection.
Results: In every case, at least one radioactive SLN was identified with the subareolar injection of technetium; a blue SLN was found in 97% of the cases. The blue SLN was also radioactive in 98% of the cases, indicating that the blue dye injected around the tumor and the technetium injected into the subareolar location drained to the same SLN.
Conclusions: Subareolar injection of technetium can improve SLN identification rates for breast cancer. The simplicity and accuracy of this technique may also reduce the variable results reported with the standard intraparenchymal method.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Martin RC II, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study.Surgery 2000;128:139–44.
McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.J Clin Oncol 2000;18:2560–6.
McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify sentinel lymph nodes.Ann Surg 2000;231:724–31.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study.N Engl J Med 1998;339:941–6.
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 1994;220:391–401.
Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 1993;2:335–40.
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 1996;276:1818–22.
Edwards MJ, Giuliano A, Reintgen D, et al. Consensus statement on sentinel lymph node biopsy: guidelines for performance of sentinel lymph node biopsy for breast cancer. American Society of Breast Surgeons. 2000. Available at: http://www.breastsurgeons.org/sentinel.htm. Accessed October 30, 2001.
Halsell J, Smith J, Bentlage C, Park O, Humphreys J. Lymphatic drainage of the breast demonstrated by vital dye staining and radiography.Ann Surg 1963;162:221–6.
Klimberg V, Rubio I, Henry R, Cowan C, Colvert M, Korourian S. Subareolar versus peritumoral injection for location of the sentinel lymph node.Ann Surg 1999;229:860–5.
Kern K. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye.J Am Coll Surg 1999;189:539–45.
Louis TA. Confidence intervals for a binomial parameter after observing no successes.Am Stat 1981;35:154.
Le CT, Boen JR.Health and Numbers: Basic Biostatistical Methods. New York: Wiley, 1995:202–204.
Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes.Lancet 1997;349:1864–7.
Linehan D, Hill A, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.Ann Surg Oncol 1999;6:450–4.
McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.Ann Surg 2001;233:676–87.
Borgstein PJ, Meijer S, Pijpers R, Van Diest PJ. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar blue method.Ann Surg 2000;232:81–9.
Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid.J Am Coll Surg 2000;191:479–89.
Morrow M, Foster RS. Staging of breast cancer: a new rationale for internal mammary node biopsy.Arch Surg 1981;116:748–51.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuttle, T.M., Colbert, M., Christensen, R. et al. Subareolar injection of99mTc facilitates sentinel lymph node identification. Ann Surg Oncol 9, 77–81 (2002). https://doi.org/10.1245/aso.2002.9.1.77
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1245/aso.2002.9.1.77